Status:
COMPLETED
IV PAPAVERINE Prior to Propess for Labor Induction
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
Induced Vaginal Delivery
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
The investigators aim to evaluate the effect of administering papaverine prior to PGE2 insertion on changes in Bishop-scores and on the induction-to-delivery interval. Researchers will compare drug p...
Detailed Description
More than 22% of all pregnant women undergo induction of labor. Induction of labor is usually medically indicated for maternal and fetal related conditions; however, elective induction has become more...
Eligibility Criteria
Inclusion
- singleton term pregnancy
- bishop score
- need for labor induction with PGE2
- vertex presentation
- viable fetus
Exclusion
- Prelabour rupture of membrane
- Twins pregnancy
- previous cesarean section
- allergy to the study medication
- fetal anomaly contraindications for vaginal delivery
- maternal supraventricular tachicardia
Key Trial Info
Start Date :
August 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06550232
Start Date
August 12 2024
End Date
March 23 2025
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Galilee Medical Center
Nahariya, Israel